 | • レポートコード：MRC2-11QY11672 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は拡張型心筋症のグローバル市場について調査・分析したレポートです。種類別（利尿薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシンII受容体拮抗薬（ARB）、ベータ遮断薬、間伐薬、強心配糖体、その他）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別拡張型心筋症の競争状況、市場シェア ・世界の拡張型心筋症市場：種類別市場規模 2015年-2020年（利尿薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシンII受容体拮抗薬（ARB）、ベータ遮断薬、間伐薬、強心配糖体、その他） ・世界の拡張型心筋症市場：種類別市場規模予測 2021年-2026年（利尿薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシンII受容体拮抗薬（ARB）、ベータ遮断薬、間伐薬、強心配糖体、その他） ・世界の拡張型心筋症市場：用途別市場規模 2015年-2020年（病院、クリニック、その他） ・世界の拡張型心筋症市場：用途別市場規模予測 2021年-2026年（病院、クリニック、その他） ・北米の拡張型心筋症市場分析：米国、カナダ ・ヨーロッパの拡張型心筋症市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの拡張型心筋症市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の拡張型心筋症市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの拡張型心筋症市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：ZensunSci＆tech、Capricor Therapeutics、Aastrom Biosciences、t2cure GmbH、MyoKardia、Kasiak Research ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Dilated Cardiomyopathy (DCM) refers to the cardiac hypertrophy, cannot effectively pump blood.
Dilated Cardiomyopathy (DCM) is due to genetic or other disease caused by a heart disease, it respectively affect the ventricles of the heart and heart, the inferior vena chamber and the upper Chambers of the heart.
Market Analysis and Insights: Global Dilated Cardiomyopathy Market
The global Dilated Cardiomyopathy market size is projected to reach US$ 28 million by 2026, from US$ 28 million in 2020, at a CAGR of 2.7%% during 2021-2026.
Global Dilated Cardiomyopathy Scope and Market Size
Dilated Cardiomyopathy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dilated Cardiomyopathy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
ZensunSci＆tech
Capricor Therapeutics
Aastrom Biosciences
t2cure GmbH
MyoKardia
Kasiak Research
…
Market segment by Type, the product can be split into
Diuretics
Angiotensin-Converting Enzyme (ACE) Inhibitors
Angiotensin II Receptor Blockers (ARBs)
Beta Blockers
Blood Thinning Medications
Cardiac Glycosides
Others
Market segment by Application, split into
Hospital
Clinic
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Dilated Cardiomyopathy Revenue
1.4 Market by Type
1.4.1 Global Dilated Cardiomyopathy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Diuretics
1.4.3 Angiotensin-Converting Enzyme (ACE) Inhibitors
1.4.4 Angiotensin II Receptor Blockers (ARBs)
1.4.5 Beta Blockers
1.4.6 Blood Thinning Medications
1.4.7 Cardiac Glycosides
1.4.8 Others
1.5 Market by Application
1.5.1 Global Dilated Cardiomyopathy Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Dilated Cardiomyopathy Market Perspective (2015-2026)
2.2 Global Dilated Cardiomyopathy Growth Trends by Regions
2.2.1 Dilated Cardiomyopathy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Dilated Cardiomyopathy Historic Market Share by Regions (2015-2020)
2.2.3 Dilated Cardiomyopathy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Dilated Cardiomyopathy Market Growth Strategy
2.3.6 Primary Interviews with Key Dilated Cardiomyopathy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Dilated Cardiomyopathy Players by Market Size
3.1.1 Global Top Dilated Cardiomyopathy Players by Revenue (2015-2020)
3.1.2 Global Dilated Cardiomyopathy Revenue Market Share by Players (2015-2020)
3.1.3 Global Dilated Cardiomyopathy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Dilated Cardiomyopathy Market Concentration Ratio
3.2.1 Global Dilated Cardiomyopathy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Dilated Cardiomyopathy Revenue in 2019
3.3 Dilated Cardiomyopathy Key Players Head office and Area Served
3.4 Key Players Dilated Cardiomyopathy Product Solution and Service
3.5 Date of Enter into Dilated Cardiomyopathy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Dilated Cardiomyopathy Historic Market Size by Type (2015-2020)
4.2 Global Dilated Cardiomyopathy Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Dilated Cardiomyopathy Market Size by Application (2015-2020)
5.2 Global Dilated Cardiomyopathy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Dilated Cardiomyopathy Market Size (2015-2020)
6.2 Dilated Cardiomyopathy Key Players in North America (2019-2020)
6.3 North America Dilated Cardiomyopathy Market Size by Type (2015-2020)
6.4 North America Dilated Cardiomyopathy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Dilated Cardiomyopathy Market Size (2015-2020)
7.2 Dilated Cardiomyopathy Key Players in Europe (2019-2020)
7.3 Europe Dilated Cardiomyopathy Market Size by Type (2015-2020)
7.4 Europe Dilated Cardiomyopathy Market Size by Application (2015-2020)
8 China
8.1 China Dilated Cardiomyopathy Market Size (2015-2020)
8.2 Dilated Cardiomyopathy Key Players in China (2019-2020)
8.3 China Dilated Cardiomyopathy Market Size by Type (2015-2020)
8.4 China Dilated Cardiomyopathy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Dilated Cardiomyopathy Market Size (2015-2020)
9.2 Dilated Cardiomyopathy Key Players in Japan (2019-2020)
9.3 Japan Dilated Cardiomyopathy Market Size by Type (2015-2020)
9.4 Japan Dilated Cardiomyopathy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Dilated Cardiomyopathy Market Size (2015-2020)
10.2 Dilated Cardiomyopathy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Dilated Cardiomyopathy Market Size by Type (2015-2020)
10.4 Southeast Asia Dilated Cardiomyopathy Market Size by Application (2015-2020)
11 India
11.1 India Dilated Cardiomyopathy Market Size (2015-2020)
11.2 Dilated Cardiomyopathy Key Players in India (2019-2020)
11.3 India Dilated Cardiomyopathy Market Size by Type (2015-2020)
11.4 India Dilated Cardiomyopathy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Dilated Cardiomyopathy Market Size (2015-2020)
12.2 Dilated Cardiomyopathy Key Players in Central & South America (2019-2020)
12.3 Central & South America Dilated Cardiomyopathy Market Size by Type (2015-2020)
12.4 Central & South America Dilated Cardiomyopathy Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 ZensunSci＆tech
13.1.1 ZensunSci＆tech Company Details
13.1.2 ZensunSci＆tech Business Overview
13.1.3 ZensunSci＆tech Dilated Cardiomyopathy Introduction
13.1.4 ZensunSci＆tech Revenue in Dilated Cardiomyopathy Business (2015-2020))
13.1.5 ZensunSci＆tech Recent Development
13.2 Capricor Therapeutics
13.2.1 Capricor Therapeutics Company Details
13.2.2 Capricor Therapeutics Business Overview
13.2.3 Capricor Therapeutics Dilated Cardiomyopathy Introduction
13.2.4 Capricor Therapeutics Revenue in Dilated Cardiomyopathy Business (2015-2020)
13.2.5 Capricor Therapeutics Recent Development
13.3 Aastrom Biosciences
13.3.1 Aastrom Biosciences Company Details
13.3.2 Aastrom Biosciences Business Overview
13.3.3 Aastrom Biosciences Dilated Cardiomyopathy Introduction
13.3.4 Aastrom Biosciences Revenue in Dilated Cardiomyopathy Business (2015-2020)
13.3.5 Aastrom Biosciences Recent Development
13.4 t2cure GmbH
13.4.1 t2cure GmbH Company Details
13.4.2 t2cure GmbH Business Overview
13.4.3 t2cure GmbH Dilated Cardiomyopathy Introduction
13.4.4 t2cure GmbH Revenue in Dilated Cardiomyopathy Business (2015-2020)
13.4.5 t2cure GmbH Recent Development
13.5 MyoKardia
13.5.1 MyoKardia Company Details
13.5.2 MyoKardia Business Overview
13.5.3 MyoKardia Dilated Cardiomyopathy Introduction
13.5.4 MyoKardia Revenue in Dilated Cardiomyopathy Business (2015-2020)
13.5.5 MyoKardia Recent Development
13.6 Kasiak Research
13.6.1 Kasiak Research Company Details
13.6.2 Kasiak Research Business Overview
13.6.3 Kasiak Research Dilated Cardiomyopathy Introduction
13.6.4 Kasiak Research Revenue in Dilated Cardiomyopathy Business (2015-2020)
13.6.5 Kasiak Research Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Dilated Cardiomyopathy Key Market Segments
Table 2. Key Players Covered: Ranking by Dilated Cardiomyopathy Revenue
Table 3. Ranking of Global Top Dilated Cardiomyopathy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Dilated Cardiomyopathy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Diuretics
Table 6. Key Players of Angiotensin-Converting Enzyme (ACE) Inhibitors
Table 7. Key Players of Angiotensin II Receptor Blockers (ARBs)
Table 8. Key Players of Beta Blockers
Table 9. Key Players of Blood Thinning Medications
Table 10. Key Players of Cardiac Glycosides
Table 11. Key Players of Others
Table 12. Global Dilated Cardiomyopathy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Dilated Cardiomyopathy Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Dilated Cardiomyopathy Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Dilated Cardiomyopathy Market Share by Regions (2015-2020)
Table 16. Global Dilated Cardiomyopathy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Dilated Cardiomyopathy Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Dilated Cardiomyopathy Market Growth Strategy
Table 22. Main Points Interviewed from Key Dilated Cardiomyopathy Players
Table 23. Global Dilated Cardiomyopathy Revenue by Players (2015-2020) (Million US$)
Table 24. Global Dilated Cardiomyopathy Market Share by Players (2015-2020)
Table 25. Global Top Dilated Cardiomyopathy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dilated Cardiomyopathy as of 2019)
Table 26. Global Dilated Cardiomyopathy by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Dilated Cardiomyopathy Product Solution and Service
Table 29. Date of Enter into Dilated Cardiomyopathy Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Dilated Cardiomyopathy Market Size by Type (2015-2020) (Million US$)
Table 32. Global Dilated Cardiomyopathy Market Size Share by Type (2015-2020)
Table 33. Global Dilated Cardiomyopathy Revenue Market Share by Type (2021-2026)
Table 34. Global Dilated Cardiomyopathy Market Size Share by Application (2015-2020)
Table 35. Global Dilated Cardiomyopathy Market Size by Application (2015-2020) (Million US$)
Table 36. Global Dilated Cardiomyopathy Market Size Share by Application (2021-2026)
Table 37. North America Key Players Dilated Cardiomyopathy Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Dilated Cardiomyopathy Market Share (2019-2020)
Table 39. North America Dilated Cardiomyopathy Market Size by Type (2015-2020) (Million US$)
Table 40. North America Dilated Cardiomyopathy Market Share by Type (2015-2020)
Table 41. North America Dilated Cardiomyopathy Market Size by Application (2015-2020) (Million US$)
Table 42. North America Dilated Cardiomyopathy Market Share by Application (2015-2020)
Table 43. Europe Key Players Dilated Cardiomyopathy Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Dilated Cardiomyopathy Market Share (2019-2020)
Table 45. Europe Dilated Cardiomyopathy Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Dilated Cardiomyopathy Market Share by Type (2015-2020)
Table 47. Europe Dilated Cardiomyopathy Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Dilated Cardiomyopathy Market Share by Application (2015-2020)
Table 49. China Key Players Dilated Cardiomyopathy Revenue (2019-2020) (Million US$)
Table 50. China Key Players Dilated Cardiomyopathy Market Share (2019-2020)
Table 51. China Dilated Cardiomyopathy Market Size by Type (2015-2020) (Million US$)
Table 52. China Dilated Cardiomyopathy Market Share by Type (2015-2020)
Table 53. China Dilated Cardiomyopathy Market Size by Application (2015-2020) (Million US$)
Table 54. China Dilated Cardiomyopathy Market Share by Application (2015-2020)
Table 55. Japan Key Players Dilated Cardiomyopathy Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Dilated Cardiomyopathy Market Share (2019-2020)
Table 57. Japan Dilated Cardiomyopathy Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Dilated Cardiomyopathy Market Share by Type (2015-2020)
Table 59. Japan Dilated Cardiomyopathy Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Dilated Cardiomyopathy Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Dilated Cardiomyopathy Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Dilated Cardiomyopathy Market Share (2019-2020)
Table 63. Southeast Asia Dilated Cardiomyopathy Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Dilated Cardiomyopathy Market Share by Type (2015-2020)
Table 65. Southeast Asia Dilated Cardiomyopathy Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Dilated Cardiomyopathy Market Share by Application (2015-2020)
Table 67. India Key Players Dilated Cardiomyopathy Revenue (2019-2020) (Million US$)
Table 68. India Key Players Dilated Cardiomyopathy Market Share (2019-2020)
Table 69. India Dilated Cardiomyopathy Market Size by Type (2015-2020) (Million US$)
Table 70. India Dilated Cardiomyopathy Market Share by Type (2015-2020)
Table 71. India Dilated Cardiomyopathy Market Size by Application (2015-2020) (Million US$)
Table 72. India Dilated Cardiomyopathy Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Dilated Cardiomyopathy Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Dilated Cardiomyopathy Market Share (2019-2020)
Table 75. Central & South America Dilated Cardiomyopathy Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Dilated Cardiomyopathy Market Share by Type (2015-2020)
Table 77. Central & South America Dilated Cardiomyopathy Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Dilated Cardiomyopathy Market Share by Application (2015-2020)
Table 79. ZensunSci＆tech Company Details
Table 80. ZensunSci＆tech Business Overview
Table 81. ZensunSci＆tech Product
Table 82. ZensunSci＆tech Revenue in Dilated Cardiomyopathy Business (2015-2020) (Million US$)
Table 83. ZensunSci＆tech Recent Development
Table 84. Capricor Therapeutics Company Details
Table 85. Capricor Therapeutics Business Overview
Table 86. Capricor Therapeutics Product
Table 87. Capricor Therapeutics Revenue in Dilated Cardiomyopathy Business (2015-2020) (Million US$)
Table 88. Capricor Therapeutics Recent Development
Table 89. Aastrom Biosciences Company Details
Table 90. Aastrom Biosciences Business Overview
Table 91. Aastrom Biosciences Product
Table 92. Aastrom Biosciences Revenue in Dilated Cardiomyopathy Business (2015-2020) (Million US$)
Table 93. Aastrom Biosciences Recent Development
Table 94. t2cure GmbH Company Details
Table 95. t2cure GmbH Business Overview
Table 96. t2cure GmbH Product
Table 97. t2cure GmbH Revenue in Dilated Cardiomyopathy Business (2015-2020) (Million US$)
Table 98. t2cure GmbH Recent Development
Table 99. MyoKardia Company Details
Table 100. MyoKardia Business Overview
Table 101. MyoKardia Product
Table 102. MyoKardia Revenue in Dilated Cardiomyopathy Business (2015-2020) (Million US$)
Table 103. MyoKardia Recent Development
Table 104. Kasiak Research Company Details
Table 105. Kasiak Research Business Overview
Table 106. Kasiak Research Product
Table 107. Kasiak Research Revenue in Dilated Cardiomyopathy Business (2015-2020) (Million US$)
Table 108. Kasiak Research Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dilated Cardiomyopathy Market Share by Type: 2020 VS 2026
Figure 2. Diuretics Features
Figure 3. Angiotensin-Converting Enzyme (ACE) Inhibitors Features
Figure 4. Angiotensin II Receptor Blockers (ARBs) Features
Figure 5. Beta Blockers Features
Figure 6. Blood Thinning Medications Features
Figure 7. Cardiac Glycosides Features
Figure 8. Others Features
Figure 9. Global Dilated Cardiomyopathy Market Share by Application: 2020 VS 2026
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Others Case Studies
Figure 13. Dilated Cardiomyopathy Report Years Considered
Figure 14. Global Dilated Cardiomyopathy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Dilated Cardiomyopathy Market Share by Regions: 2020 VS 2026
Figure 16. Global Dilated Cardiomyopathy Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Dilated Cardiomyopathy Market Share by Players in 2019
Figure 19. Global Top Dilated Cardiomyopathy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dilated Cardiomyopathy as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Dilated Cardiomyopathy Revenue in 2019
Figure 21. North America Dilated Cardiomyopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Dilated Cardiomyopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Dilated Cardiomyopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Dilated Cardiomyopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Dilated Cardiomyopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Dilated Cardiomyopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Dilated Cardiomyopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed
拡張型心筋症治療の世界市場（～2026年） Dilated Cardiomyopathy (DCM) is a condition in which heart's left ventricle, is enlarged and weakened and the ability to pump blood is decreased. The growth in DCM treatment market is due to prominent rise in number of heart failure patients worldwide over the years, R&D activities and increased awa…- 心筋症の世界市場（～2026年） Cardiomyopathy refers to diseases of the heart muscle The major factors that contributes in the growth of the market are advancement in understanding and managing cardiomyopathy and rise in incidences of congestive heart failure, coronary heart disease, and heart attack. Further, increasing trend of…
- 肥大型心筋症治療薬の世界市場（～2026年） HCM is the enlargement of the heart muscle (myocardium), which disrupts the functions of the heart. HCM is mostly caused due to gene mutation and is a significant cause of sudden cardiac death in any age group. Hypertrophy is defined as an enlargement of a tissue or organ, and cardiomyopathy refers …
- 肥大型心筋症（HCM）治療薬の世界市場（～2026年） Hypertrophic Cardiomyopathy (HCM) is a condition in which a portion of the heart becomes thickened without an obvious cause. This results in the heart being less able to pump blood effectively. Symptoms vary from none to feeling tired, leg swelling, and shortness of breath. It may also result in che…
- アンジオテンシンII受容体の世界市場（～2026年） Market Analysis and Insights: Global Angiotensin II Receptor Market The global Angiotensin II Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Angiotensin II Receptor Scope and Market Size Angiotensin II Recept…